Skip to main content
Curasight A/S logo

Curasight A/S — Investor Relations & Filings

Ticker · CURAS ISIN · DK0061295797 LEI · 984500C9E3ADR98F1070 SPGR Manufacturing
Open in API
Filings indexed 15 across all filing types
Latest filing 2025-05-15 Director's Dealing
Country DK Denmark
Listing SPGR CURAS

About Curasight A/S

https://www.curasight.com/

Curasight A/S is a clinical-stage biotechnology company focused on improving the diagnosis and treatment of various cancers. The company is developing a novel theranostic platform targeting the urokinase-type plasminogen activator receptor (uPAR), a biomarker for cancer aggressiveness. This platform integrates two main components: uTRACE®, a diagnostic agent for precise Positron Emission Tomography (PET) imaging, and uTREAT®, a targeted radionuclide therapy. The uTRACE® diagnostic identifies patients with uPAR-positive tumors, enabling subsequent treatment with uTREAT®. This approach aims to deliver radiation directly to cancer cells, minimizing exposure to healthy tissue and providing a more gentle and efficient therapeutic option. The company's technology is being advanced through multiple phase II clinical trials.

Recent filings

Filing Released Lang Actions
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a standard regulatory form used in Denmark (Finanstilsynet) for reporting transactions by persons discharging managerial responsibilities (PDMRs). It explicitly identifies the individual (Jacob Madsen, Director CMC and co-founder), the issuer (Curasight A/S), and details the transaction (purchase of shares). This falls under the category of Director's Dealing (insider trading notification).
2025-05-15 Danish
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by company directors and executives (insiders) in relation to a rights issue. It includes specific regulatory forms (FINANSTILSYNET) required for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the Market Abuse Regulation (MAR). This aligns perfectly with the definition of 'Director's Dealing'.
2025-05-15 English
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a standard regulatory form (Finanstilsynet) used to report transactions by persons discharging managerial responsibilities (PDMRs). It details the name of the individual (Andreas Kjær), their role (CMO/CSO/Board member), the issuer (Curasight A/S), and specific details of the share transaction (purchase of shares). This falls under the category of Director's Dealing (insider trading notification).
2025-05-15 Danish
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by company directors and executives (insiders) in relation to a rights issue. It includes specific regulatory forms (FINANSTILSYNET) required for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the Market Abuse Regulation (MAR). This aligns perfectly with the definition of 'Director's Dealing'.
2025-05-15 English
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a standard regulatory form used in the EU (specifically Denmark, indicated by 'Finanstilsynet') for reporting transactions by persons discharging managerial responsibilities (PDMRs). It details a specific share purchase by a board member (Lars Trolle) of Curasight A/S. This falls under the category of 'Director's Dealing' (insider trading/transactions).
2025-05-15 Danish
Udnyttelse af tegningsretter Curasight TO i Curasight A/S
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by company directors and executives (insiders) in relation to a rights issue. It includes specific regulatory forms (FINANSTILSYNET) required for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the Market Abuse Regulation (MAR). This aligns perfectly with the definition of 'Director's Dealing'.
2025-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.